New Antithrombotic Strategies: Do They Increase Clinical Benefits?

 

 

 

By: Dr. Gustavo Olmedo F., FESC – FACC
Departamento de cardiologia
Hospital de Clínicas

Important:

The intellectual property rights to the presentations and content available on this website belong to their respective owners and/or SOLACI. Their publication on SOLACI is carried out under strict authorization for scientific, medical, and educational purposes. Any reproduction, distribution, modification, or other use is expressly prohibited without the prior written consent of the rights holders and/or SOLACI.

More articles by this author

Current Indications for Statins According to Age Groups and Associated Risk Factors

    Por: Dr. Jorge Enrique Solano-López F.A.C.P Important: The intellectual property rights to the presentations and content available on this website belong to their respective owners and/or...

Surgical Aortic Valve Replacement: PARTNER 5-Year Results

    By: Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil Important: The intellectual property rights to the presentations and content available on...

Severe Aortic Stenosis With Low Flow, Low Gradient, and Systolic Dysfunction

  By: Rubén G. Servián C. MD Departamento de Imágenes – Hospital Central Instituto de Previsión Social (I.P.S.) Important: The intellectual property rights to the presentations and content available...

Cardiovascular Disease Prevention and Physical Exercise in Adults: Is It a Matter of Intensity?

    By: Dra. María Carolina Acosta Cazal Important: The intellectual property rights to the presentations and content available on this website belong to their respective owners and/or...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Shortened DAPT Regimens According to the PRECISE-HBR Score

The optimal duration of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention depends on balancing the prevention of ischemic events against the risk of...

SAFE-PROTECT at 12 Months: AnchorMan vs. Watchman for Left Atrial Appendage Closure

Percutaneous left atrial appendage (LAA) closure is an alternative therapeutic strategy for reducing the risk of stroke in patients with atrial fibrillation (AF). Randomized...

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...